Abstract
The toxic effects of repeated intravitreal injections of selected chemotherapeutic agents were studied in female albino rabbits. Three groups of eyes participated in each therapeutic regimen. Agents studied were doxorubicin (dox), 3 and 5ug; 5-fluorouracil (5-FU), 0.375 and 1.0 mg; bleomycin (bleo), 15 ug; thiotepa (thio), 12 ug; etoposide (VP-16), 150 ug; and methotrexate (MTX), 600 ug. Toxicity was evaluated using electroretinography (ERG) in 66% and histopathology in 100% of eyes 5 weeks following the initial injection and at least 2 weeks after the final injection of each series. Eyes receiving 2 doses of dox 3 ug showed no toxicity. Eyes receiving 3 or more doses of dox 3 ug and those treated with 2 or more doses of dox 5 demonstrated toxicity proportional to the number of doses received.
Eyes treated with 5-FU 0.375 or 1.0 mg showed no toxic reaction. Successive intravitreal injections of 5-FU, 0.375 mg and dox 5 ug, and 5-FU, dox, and bleo produced no toxicity. Eyes treated with successive intravitreal injections of 5-FU, dox, bleo, and thio displayed decreased ERG response. The addition of VP-16 and MTX resulted in further loss of ERG response and more severe histologic retinal changes.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Barrada, A. & G.A. Peyman. Evaluation of intravitreal 5-fluorouracil, vincristine, VP-16, doxorubicin, and thiotepa in primates eyes. Ophthalmic Surg. 15: 767–769 (1984).
Barrada, A., G.A. Peyman & D. Greenberg et al. Toxicity of antineoplastic drugs in vitrectomy infusion fluids. Ophthalmic Surg. 14: 845–847 (1983).
Binder, S., B. Riss & C.H. Skorpik et al. Toxicity of antineoplastic drugs in vitrectomy infusion fluids. Ophthalmic Surg. 14: 845–847 (1983).
Blumenkranz, M., A. Claflin & A. Hajek. Selection of therapeutic agents for intraocular proliferative disease: Cell culture evaluation. Arch. Ophthalmol. 102: 598 (1984).
Blumenkranz, M., E. Hernandez, A. Ophir et al. 5-Fluorouracil: New applications in complicated retinal detachment for an established antimetabolite. Ophthalmology 91: 122–130 (1984).
Blumenkranz, M.S., A. Ophir, A.J. Caflin et al. Fluorouracil for the treatment of massive preretinal proliferation. Am. J. Ophthalmol. 94: 458–467 (1982).
Case, J.L., G.A. Peyman, A. Barrada et al. Clearance of intravitreal 3H-fluorouracil. Ophthalmic Surg. 16: 378–381 (1985).
Dorr, R.T. & W.L. Fritz. Cancer Chemotherapy Hand-book. New York, Elsevier (1980).
McEvoy, G.K. (ed). Drug Information 84. Am. Hosp. Formulary Service (1984).
Fraunfelder, F.T. & F.N. Meier. Ocular toxicity of entineoplastic agents. Ophthalmology 90: 1–3 (1983).
Griffin, J.D. & M.B. Garnick. Eye-toxicity of cancer chemotherapy: A review of the literature. Cancer 48: 1539–1549 (1981).
Kirmani, M. & M. Santa. Drug treatment of M-P-P. Invest. Ophthalmol. Visual Science 24 Suppl: 241 (1983).
Kulnig, W., S. Binder & B. Wiss: Inhibition of experimental intraocular proliferation with intravenous 5-Fluorouracil. Ophthalmology 188: 248–258 (1984).
Lewis, G.P., C.J. Guerin, P.A. Erickson et al. Reversible toxicity of 5-Fluorouracil treatment for proliferative retinopathy. Invest Ophthalmol. Visual Science 24 Suppl.: 241 (1983).
Nao-i, N. & Y. Honda. Toxic effect of fluorouracil on the rabbit retina. Am. J. Ophthalmol. 96: 641 (1983).
Okeda, R., T. Karajama, S. Kimura et al. Neuropathological study on chronic neurotoxicity of 5-fluorouracil. Acta Neuropathol. 63: 334–343 (1984).
Peyman, G.A. & A. Barada. Toxicity of antineoplastic drug combination in vitrectomy infusion fluid. Ophthalmic Surg. 15: 844–846 (1984).
Peyman, G.A. & D. Greenberg. Evaluation of toxicity of intravitreal antineoplastic drugs. Ophthalmic Surg. 15: 411–413 (1984).
Peyman, G.A. & J. Schulman. Proliferative vitreoretinopathy and chemotherapeutic agents. Surv. Ophthalmol. 29(6): 434–442 (1985).
Rootman, J., G. Tisdall, G. Gudauskas et al. Intraocular penetration of subconjunctivally administered 14C-fluorouracil in rabbits. Arch. Ophthalmol. 97: 2375–2378 (1979).
Stern, W.H. & C.J. Guerin. Ocular toxicity of fluorouracil after vitrectomy. Am. J. Ophthalmol. 96: 43–51 (1983).
Vizel, M. & M.W. Oster. Ocular side effects of cancer chemotherapy. Cancer 49: 1999–2002 (1982).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Vernot, J., Peyman, G.A., Gailitis, R. et al. Effects of selected repeated intravitreal chemotherapeutic agents. Int Ophthalmol 8, 193–198 (1985). https://doi.org/10.1007/BF00137646
Issue Date:
DOI: https://doi.org/10.1007/BF00137646